Prognosis of EBV-positive gastric cancer with lymphoid stroma: systematic review and meta-analysis

References

• Smyth EC, Nilsson M, Grabsch HI, et al. Gastric cancer. Lancet. 2020;396(10251):635–648. doi: 10.1016/S0140-6736(20)31288-5.
   PubMed Web of Science ®Google Scholar
• Omran AR. The epidemiologic transition: a theory of the epidemiology of population change. Milbank Q. 2005;83(4):731–757. doi: 10.1111/j.1468-0009.2005.00398.x.
   PubMed Web of Science ®Google Scholar
• Chen T, Xu X-Y, Zhou P-H. Emerging molecular classifications and therapeutic implications for gastric cancer. Chin J Cancer. 2016;35(1):49. doi: 10.1186/s40880-016-0111-5.
   PubMed Web of Science ®Google Scholar
• Yang L, Ying X, Liu S, et al. Gastric cancer: epidemiology, risk factors and prevention strategies. Chin J Cancer Res. 2020;32(6):695–704. doi: 10.21147/j.issn.1000-9604.2020.06.03.
   PubMed Web of Science ®Google Scholar
• Nishikawa J, Iizasa H, Yoshiyama H, et al. Clinical importance of Epstein-Barr virus-associated gastric cancer. Cancers. 2018;10(6):167. doi: 10.3390/cancers10060167.
   PubMed Web of Science ®Google Scholar
• Sohn BH, Hwang J-E, Jang H-J, et al. Clinical significance of four molecular subtypes of gastric cancer identified by The Cancer Genome Atlas project. Clin Cancer Res. 2017;23(15):4441–4449. doi: 10.1158/1078-0432.CCR-16-2211.
   PubMed Web of Science ®Google Scholar
• Nakayama A, Abe H, Kunita A, et al. Viral loads correlate with upregulation of PD-L1 and worse patient prognosis in Epstein-Barr virus-associated gastric carcinoma. PLOS One. 2019;14(1):e0211358. doi: 10.1371/journal.pone.0211358.
   PubMed Web of Science ®Google Scholar
• Nogueira C, Mota M, Gradiz R, et al. Prevalence and characteristics of Epstein-Barr virus-associated gastric carcinomas in Portugal. Infect Agent Cancer. 2017;12:41.
   PubMed Web of Science ®Google Scholar
• Cheng N, Hui D-y, Liu Y, et al. Is gastric lymphoepithelioma-like carcinoma a special subtype of EBV-associated gastric carcinoma? New insight based on clinicopathological features and EBV genome polymorphisms. Gastric Cancer. 2015;18(2):246–255. doi: 10.1007/s10120-014-0376-9.
   PubMed Web of Science ®Google Scholar
• Chetty R. Gastrointestinal cancers accompanied by a dense lymphoid component: an overview with special reference to gastric and colonic medullary and lymphoepithelioma-like carcinomas. J Clin Pathol. 2012;65(12):1062–1065. doi: 10.1136/jclinpath-2012-201067.
   PubMed Web of Science ®Google Scholar
• Grogg KL, Lohse CM, Pankratz VS, et al. Lymphocyte-rich gastric cancer: associations with Epstein-Barr virus, microsatellite instability, histology, and survival. Mod Pathol. 2003;16(7):641–651. doi: 10.1097/01.MP.0000076980.73826.C0.
   PubMed Web of Science ®Google Scholar
• Herath CHP, Chetty R. Epstein-Barr virus-associated lymphoepithelioma-like gastric carcinoma. Arch Pathol Lab Med. 2008;132(4):706–709. doi: 10.5858/2008-132-706-EVLGC.
   PubMed Web of Science ®Google Scholar
• Watanabe H, Enjoji M, Imai T. Gastric carcinoma with lymphoid stroma. Its morphologic characteristics and prognostic correlations. Cancer. 1976;38(1):232–243. doi: 10.1002/1097-0142(197607)38:1<232::AID-CNCR2820380135>3.0.CO;2-4.
   PubMed Web of Science ®Google Scholar
• Osumi H, Kawachi H, Yoshio T, et al. Clinical impact of Epstein-Barr virus status on the incidence of lymph node metastasis in early gastric cancer. Dig Endosc. 2020;32(3):316–322. doi: 10.1111/den.13584.
   PubMed Web of Science ®Google Scholar
• Matsunou H, Konishi F, Hori H, et al. Characteristics of Epstein-Barr virus-associated gastric carcinoma with lymphoid stroma in Japan. Cancer. 1996;77(10):1998–2004. doi: 10.1002/(SICI)1097-0142(19960515)77:10<1998::AID-CNCR6>3.0.CO;2-D.
   PubMed Web of Science ®Google Scholar
• Stroup DF, Berlin JA, Morton SC, et al. Meta-Analysis of Observational Studies in Epidemiology: a proposal for reporting. Meta-Analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–2012. doi: 10.1001/jama.283.15.2008.
   PubMed Web of Science ®Google Scholar
• Pyo J-S, Kim NY, Son BK, et al. Clinicopathological features and prognostic implication of gastric carcinoma with lymphoid stroma. Gastroenterol Res Pract. 2020;2020:6628412–6628419. doi: 10.1155/2020/6628412.
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560. doi: 10.1136/bmj.327.7414.557.
   PubMed Web of Science ®Google Scholar
• Cho CJ, Kang HJ, Ryu Y-M, et al. Poor prognosis in Epstein-Barr virus-negative gastric cancer with lymphoid stroma is associated with immune phenotype. Gastric Cancer. 2018;21(6):925–935. doi: 10.1007/s10120-018-0820-3.
   PubMed Web of Science ®Google Scholar
• Fang W-L, Chen M-H, Huang K-H, et al. The clinicopathological features and genetic alterations in Epstein-Barr virus-associated gastric cancer patients after curative surgery. Cancers. 2020;12(6):1517. doi: 10.3390/cancers12061517.
   PubMed Web of Science ®Google Scholar
• Hissong E, Ramrattan G, Zhang P, et al. Gastric carcinomas with lymphoid stroma: an evaluation of the histopathologic and ­molecular features. Am J Surg Pathol. 2018;42(4):453–462. doi: 10.1097/PAS.0000000000001018.
   PubMed Web of Science ®Google Scholar
• Lim H, Park YS, Lee JH, et al. Features of gastric carcinoma with lymphoid stroma associated with Epstein-Barr virus. Clin Gastroenterol Hepatol. 2015;13(10):1738–1744.e2.
   PubMed Web of Science ®Google Scholar
• Min B-H, Tae CH, Ahn SM, et al. Epstein-Barr virus infection serves as an independent predictor of survival in patients with lymphoepithelioma-like gastric carcinoma. Gastric Cancer. 2016;19(3):852–859. doi: 10.1007/s10120-015-0524-x.
   PubMed Web of Science ®Google Scholar
• Mohri T, Nagata K, Kuwamoto S, et al. Aberrant expression of AID and AID activators of NF-κB and PAX5 is irrelevant to EBV-associated gastric cancers, but is associated with carcinogenesis in certain EBV-non-associated gastric cancers. Oncol Lett. 2017;13(6):4133–4140. doi: 10.3892/ol.2017.5978.
   PubMed Web of Science ®Google Scholar
• Ramos MFKP, Pereira MA, Dias AR, et al. Lymphoepithelioma-like gastric carcinoma: clinicopathological characteristics and infection status. J Surg Res. 2017;210:159–168. doi: 10.1016/j.jss.2016.11.012.
   PubMed Web of Science ®Google Scholar
• Chang MS, Kim WH, Kim CW, et al. Epstein-Barr virus in gastric carcinomas with lymphoid stroma. Histopathology. 2000;37(4):309–315. doi: 10.1046/j.1365-2559.2000.01014.x.
   PubMed Web of Science ®Google Scholar
• Crombie JL, LaCasce AS. Epstein Barr virus associated B-cell lymphomas and iatrogenic lymphoproliferative disorders. Front Oncol. 2019;9:109. doi: 10.3389/fonc.2019.00109.
   PubMed Web of Science ®Google Scholar
• Pattle SB, Farrell PJ. The role of Epstein-Barr virus in cancer. Expert Opin Biol Ther. 2006;6(11):1193–1205. doi: 10.1517/14712598.6.11.1193.
   PubMed Web of Science ®Google Scholar
• Alruwaii ZI, Montgomery EA. Select Epstein-Barr Virus-associated digestive tract lesions for the practicing pathologist. Arch Pathol Lab Med. 2021;145(5):562–570. doi: 10.5858/arpa.2019-0703-RA.
   PubMed Web of Science ®Google Scholar
• Ignatova E, Seriak D, Fedyanin M, et al. Epstein-Barr virus-associated gastric cancer: disease that requires special approach. Gastric Cancer. 2020;23(6):951–960. doi: 10.1007/s10120-020-01095-z.
   PubMed Web of Science ®Google Scholar
• Sathirareuangchai S, Hirata K. Pulmonary lymphoepithelioma-like carcinoma. Arch Pathol Lab Med. 2019;143(8):1027–1030. doi: 10.5858/arpa.2018-0149-RS.
   PubMed Web of Science ®Google Scholar
• Hong R-L, Lin C-Y, Ting L-L, et al. Comparison of clinical and molecular surveillance in patients with advanced nasopharyngeal carcinoma after primary therapy: the potential role of quantitative analysis of circulating Epstein-Barr virus DNA. Cancer. 2004;100(7):1429–1437. doi: 10.1002/cncr.20129.
   PubMed Web of Science ®Google Scholar
• Lo YM, Chan LY, Chan AT, et al. Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. Cancer Res. 1999;59(21):5452–5455.
   PubMed Web of Science ®Google Scholar
• Zavala-Vega S, Palma-Lara I, Ortega-Soto E, et al. Role of Epstein-Barr virus in glioblastoma. Crit Rev Oncog. 2019;24(4):307–338. doi: 10.1615/CritRevOncog.2019032655.
   PubMedGoogle Scholar
• Almeida JFM, Peres KC, Teixeira ES, et al. Epstein-Barr virus and thyroid cancer. Crit Rev Oncog. 2019;24(4):369–377. doi: 10.1615/CritRevOncog.2019031618.
   PubMedGoogle Scholar